Successful treatment of severe delayed pressure angio-oedema with omalizumab. [electronic resource]
Producer: 20141010Description: 78-80 p. digitalISSN:- 1578-1267
- Adrenal Cortex Hormones -- therapeutic use
- Angioedema -- immunology
- Antibodies, Anti-Idiotypic -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Immunotherapy -- methods
- Middle Aged
- Omalizumab
- Pressure -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.